Skip to content

US · CAI

Caris Life Sciences, Inc.

Programmatic access: InvestorsCraft Valuation API · catalog

Sector
Healthcare · Biotechnology
Headquarters
Irving, TX 75039

Price · as of 2026-09-04

$25.07

Market cap 6.43B

Price history

Weekly OHLC price history for CAI, USD per share
WeekOpenHighLowCloseVolume
Jun 16, 2025 – Jun 20, 2025$27.00$30.70$25.56$27.250
Jun 23, 2025 – Jun 27, 2025$26.60$28.11$25.65$26.810
Jun 30, 2025 – Jul 3, 2025$26.50$27.09$25.80$26.540
Jul 7, 2025 – Jul 11, 2025$26.02$27.31$25.40$26.510
Jul 14, 2025 – Jul 18, 2025$26.83$33.41$26.75$30.190
Jul 21, 2025 – Jul 25, 2025$30.20$32.05$28.01$29.540
Jul 28, 2025 – Aug 1, 2025$30.14$30.14$26.97$28.040
Aug 4, 2025 – Aug 8, 2025$27.97$30.50$27.18$29.750
Aug 11, 2025 – Aug 15, 2025$30.00$39.80$28.22$36.500
Aug 18, 2025 – Aug 22, 2025$37.66$42.50$34.44$39.300
Aug 25, 2025 – Aug 29, 2025$39.21$40.40$37.25$38.390
Sep 1, 2025 – Sep 5, 2025$37.90$38.68$34.34$34.850
Sep 8, 2025 – Sep 12, 2025$34.71$35.47$33.20$34.060
Sep 15, 2025 – Sep 19, 2025$34.04$34.54$32.32$32.580
Sep 22, 2025 – Sep 26, 2025$32.29$33.37$28.20$29.190
Sep 29, 2025 – Oct 3, 2025$29.31$31.94$28.70$31.780
Oct 6, 2025 – Oct 10, 2025$32.00$33.65$30.04$30.480
Oct 13, 2025 – Oct 17, 2025$30.50$33.65$29.25$31.500
Oct 20, 2025 – Oct 24, 2025$31.76$33.13$29.38$31.070
Oct 27, 2025 – Oct 31, 2025$31.37$32.25$28.93$30.080
Nov 3, 2025 – Nov 7, 2025$30.33$31.78$22.86$25.610
Nov 10, 2025 – Nov 14, 2025$26.19$26.19$23.00$23.850
Nov 17, 2025 – Nov 21, 2025$23.85$25.36$23.00$24.090
Nov 24, 2025 – Nov 28, 2025$24.32$25.77$24.02$25.530
Dec 1, 2025 – Dec 5, 2025$25.31$29.10$25.10$28.860
Dec 8, 2025 – Dec 12, 2025$29.19$29.19$26.02$26.760
Dec 15, 2025 – Dec 19, 2025$26.84$28.51$25.52$27.940
Dec 22, 2025 – Dec 26, 2025$28.22$28.71$27.86$28.240
Dec 29, 2025 – Jan 2, 2026$27.90$28.21$26.43$26.980
Jan 5, 2026 – Jan 9, 2026$26.77$29.32$26.23$28.510
Jan 12, 2026 – Jan 16, 2026$28.81$29.00$24.69$26.780
Jan 19, 2026 – Jan 23, 2026$26.23$26.96$24.74$25.000
Jan 26, 2026 – Jan 30, 2026$24.98$26.85$23.14$23.160
Feb 2, 2026 – Feb 6, 2026$22.86$23.99$21.18$22.000
Feb 9, 2026 – Feb 13, 2026$22.00$23.00$20.42$20.620
Feb 16, 2026 – Feb 20, 2026$20.60$21.61$18.77$19.530
Feb 23, 2026 – Feb 27, 2026$19.32$21.47$17.15$20.140
Mar 2, 2026 – Mar 6, 2026$19.70$20.94$18.49$18.590
Mar 9, 2026 – Mar 13, 2026$18.30$19.69$17.50$18.150
Mar 16, 2026 – Mar 20, 2026$18.25$19.65$17.85$18.410
Mar 23, 2026 – Mar 27, 2026$18.59$19.68$16.43$16.950
Mar 30, 2026 – Apr 2, 2026$16.86$19.62$16.28$19.290
Apr 6, 2026 – Apr 10, 2026$18.97$20.07$17.74$18.050
Apr 13, 2026 – Apr 17, 2026$18.02$21.46$17.85$21.150
Apr 20, 2026 – Apr 24, 2026$20.94$22.16$19.25$20.200
Apr 27, 2026 – May 1, 2026$20.16$20.73$17.40$18.470
May 4, 2026 – May 8, 2026$18.34$20.03$15.71$16.150
May 11, 2026 – May 15, 2026$16.18$17.22$14.19$14.550
May 18, 2026 – May 22, 2026$14.75$16.33$14.66$15.550
May 25, 2026 – May 29, 2026$15.71$17.08$15.28$16.720
Jun 1, 2026 – Jun 5, 2026$16.46$17.84$15.43$16.490
Jun 8, 2026 – Jun 12, 2026$17.49$18.23$15.78$17.970
Jun 15, 2026 – Jun 18, 2026$18.33$18.62$17.76$18.470
Jun 22, 2026 – Jun 26, 2026$18.61$19.97$16.82$18.500
Jun 29, 2026 – Jul 2, 2026$18.78$19.68$17.50$18.300
Jul 6, 2026 – Jul 10, 2026$18.03$18.80$16.73$16.990
Jul 13, 2026 – Jul 17, 2026$17.10$17.85$16.02$16.490
Jul 20, 2026 – Jul 24, 2026$16.27$16.49$15.11$15.520
Jul 27, 2026 – Jul 31, 2026$15.69$16.17$15.23$15.670
Aug 3, 2026 – Aug 7, 2026$15.92$22.77$15.84$22.740
Aug 10, 2026 – Aug 14, 2026$22.68$23.66$21.45$21.800
Aug 17, 2026 – Aug 21, 2026$22.00$26.60$20.78$26.270
Aug 24, 2026 – Aug 28, 2026$25.84$28.32$25.40$25.630
Aug 31, 2026 – Sep 4, 2026$25.35$25.62$23.62$25.070

Valuation

MetricValueUpside
IC Value$529.94+2,014%
P/E-75.26
P/B8.88
P/S6.31
EV/EBITDA413.29
PEG
P/TBV9.18

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

Annual price and model valuations for CAI, USD per share
YearPriceAIICGraham-DoddGraham Formula
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025$18.15$28.48

Historic valuation ratios

Pick a category, then toggle metrics to compare.

USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Caris Life Sciences, Inc.

        Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.

        CEO
        David Dean Halbert
        Employees
        1.85K
        Beta
        0.68

        Peer comparison

        Same-industry comparables, ranked by market cap.

        Scroll horizontally for additional metrics. Ticker column stays fixed.

        Peer comparison for CAI: basic info, valuation models, ratios, profitability, leverage, growth, cash flow, dividends, enterprise value, and Altman Z-score.
        Basic InfoIC ValuationCore ValuationProfitabilityLeverage & LiquidityGrowthCash FlowDividendsEnterprise ValueRisk
        TickerCompany NamePriceMarket CapValueUpsideP/EP/BP/SEV/EBITDAPEGP/TBVGross MarginOperating MarginNet MarginROEROICROADebt/EquityInterest CoverageCurrent RatioQuick RatioNet Debt/EBITDAEPS GrowthSales GrowthFCF GrowthFCF YieldOp Cash Flow RatioCash ROICDividend YieldDividend PayoutShareholder YieldEV/EBITEV/FCFEV/SalesAltman Z-Score
        CAICaris Life Sciences, Inc.$22.746.43B$28.48+25%-75.268.886.31413.299.1866.40%5.56%-66.25%7.09%-4.55%-9.27%0.660.797.857.17-36.80-31.11%96.97%-126.37%1.31%0.65-6.74%0.00%0.00%15.21%104.2570.315.794.22
        ABVXAbivax S.A.$125.399.21B$3.16-97%-21.5115.26-21.49-32.5616.150.00%0.00%0.00%-130.28%1384.94%-81.80%0.10-8.648.758.581.5666.07%0.72%-2.24%-2.47877.09%0.00%0.00%6.10%-26.26-41.4630.13
        CORTCorcept Therapeutics Inco…$110.6911.97B$87.88-21%34.015.154.3943.505.1598.30%5.88%13.09%14.79%15.32%11.71%0.012.922.60-1.67-33.33%12.79%-27.62%4.25%0.8548.48%0.00%0.00%7.36%66.3720.973.9013.23
        CYTKCytokinetics, Incorporate…$78.859.81B$28.19-64%-9.18-10.9381.88-9.82-37.74-10.9388.50%-695.44%-891.60%197.47%179.99%-55.55%-1.95-5.894.534.45-1.5024.33%376.56%33.77%-7.42%-2.52157.23%0.00%0.00%0.00%-12.43-14.2386.45-2.11
        HALOHalozyme Therapeutics, In…$83.599.91B$151.75+82%24.07156.295.4616.80-5.0478.13%58.45%22.69%153.59%33.35%13.81%43.8945.034.663.303.51-25.36%37.55%37.62%8.45%3.6838.81%0.00%0.00%4.49%11.8014.946.893.81
        JAZZJazz Pharmaceuticals plc$261.5716.43B$332.64+27%-30.572.522.55127.89-5.6188.21%5.26%-8.35%-8.47%1.75%-3.01%1.261.151.861.4637.17-167.51%4.88%-14.97%10.52%0.6015.74%0.00%0.00%1.15%61.8112.103.251.60
        MDGLMadrigal Pharmaceuticals,…$514.1211.88B$129.67-75%-34.6216.5610.41-35.3516.7694.14%-31.31%-30.08%-42.49%761.60%-25.05%0.59-13.454.013.60-0.59-41.32%432.05%-58.42%-1.90%-0.61482.24%0.00%0.00%0.00%-31.16-49.219.767.66
        MRNAModerna, Inc.$56.2622.32B$16.30-71%-7.252.3610.52-6.492.3955.35%-158.13%-145.16%-28.87%-65.47%-21.31%0.22-307.403.293.060.27-21.68%-39.23%-49.08%-10.10%-0.94-43.98%0.00%0.00%0.00%-5.39-8.028.523.92
        RNAAtrium Therapeutics, Inc.$11.74200.82M$9.65-18%-4.751.1412.640.411.14100.00%-412.58%-411.88%0.026.536.463.48-18.09%-0.980.00%0.00%0.00%0.400.73-1.672.14
        RYTMRhythm Pharmaceuticals, I…$110.717.59B$28.33-74%-28.8921.0329.92-30.4021.4589.73%-101.19%-103.57%-90.45%143.83%-45.05%0.01-9.334.413.920.29-28.34%45.83%2.41%-2.05%-1.0987.36%0.00%0.00%0.00%-27.57-45.3927.9012.25

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($529.94 ÷ $25.07) − 1 = +2,013.84% (IC, example).